Clinical trials
Phase 2 Wound Infection trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2019 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cumberland Pharmaceuticals | 2 |
| Washington University School of Medicine | 2 |
| Affinium Pharmaceuticals, Ltd | 1 |
| Cellceutix Corporation | 1 |
| Federal University of São Paulo | 1 |
| Forest Laboratories | 1 |
| Furiex Pharmaceuticals, Inc | 1 |
| Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. | 1 |
| Ottawa Hospital Research Institute | 1 |
| RWJ Barnabas Health at Jersey City Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wound Infection | 16 |
| Cellulitis | 6 |
| Abscess | 5 |
| Bacterial Infections | 3 |
| Gram-Positive Bacterial Infections | 3 |
| Burns | 2 |
| Surgical Wound Infection | 2 |
| Ulcer | 2 |
| Diabetic Foot | 1 |
| Endometritis | 1 |
Trials
Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.